comparemela.com

Latest Breaking News On - Acute heart failure - Page 1 : comparemela.com

Cardiol Therapeutics Inc : Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024

Cardiol Therapeutics Inc : Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis

Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Anhydrous Hydrogen Fluoride Market Worth USD 5274 7 Million

Anhydrous Hydrogen Fluoride Market Worth USD 5274 7 Million
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Anhydrous Hydrogen Fluoride (AHF) Market to Witness Huge Growth

Anhydrous Hydrogen Fluoride (AHF) Market to Witness Huge Growth
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Short-stay units may be viable alternatives for admission for acute heart failure

1. This multicentre, randomized, comparative effectiveness study found that the short-stay unit (SSU) was often as effective as hospitalization in patients with new onset of acute heart failure (AHF) and otherwise low-risk profiles. 2. There was no difference in 30- and 90-day mortality between the SSU and hospitalized patients. Evidence Rating Level: 1 (Excellent) Patients

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.